Aardvark Therapeutics Inc (AARD)

$9.09 -0.15 (-1.62%)
Market Cap 211.92M
Revenue (ttm) 0.00
Net Income (ttm) -7.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 52,200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 21.38M
Stochastic %K 41%
Beta N/A
Analysts Strong Sell
Price Target $30.50

Latest News on AARD

U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week

Feb 14, 2025, 11:50 PM EST - 5 weeks ago

U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week

AGH KMTS KRMN NPB ODYS SAIL XHLD

Aardvark Therapeutics Announces Pricing of Initial Public Offering

Feb 12, 2025, 10:38 PM EST - 5 weeks ago

Aardvark Therapeutics Announces Pricing of Initial Public Offering

U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week

Feb 8, 2025, 2:30 AM EST - 6 weeks ago

U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week

AGH EPWK FBGL HCAI KRMN NPB ODYS

Aardvark Therapeutics Starts $100 Million IPO Effort For Hunger Treatments

Feb 3, 2025, 11:52 AM EST - 7 weeks ago

Aardvark Therapeutics Starts $100 Million IPO Effort For Hunger Treatments

Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut

Jan 24, 2025, 5:02 AM EST - 2 months ago

Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut

Aardvark Therapeutics IPO Registration Document (S-1)

Jan 23, 2025, 4:57 PM EST - 2 months ago

Aardvark Therapeutics IPO Registration Document (S-1)